Found 18 matching trials
Stereotactic Body Radiotherapy (SBRT) Plus Immunotherapy for Cancer PHASE1 Study to determine the best dose of stereotactic body radiation therapy (SB...
Show More Location
University of Chicago Medical Center
Learn More & Join Trial
A Phase I Open Label Study of the Safety and Tolerability of Elotuzumab (BMS-901608) Administered in Combination With Either Lirilumab (BMS-986015) or Urelumab (BMS-663513) in Subjects With Multiple Myeloma PHASE1 To assess the safety and tolerability, characterize the dose limiting toxic...
Show More Location
University Of Arkansas For Medical Sciences
Learn More & Join Trial
Combination Study of Urelumab and Rituximab in Patients With B-cell Non-Hodgkins Lymphoma PHASE1 The purpose of the study is to determine the safety, tolerability and maxim...
Show More Location
Ucla Department Of Medicine
Learn More & Join Trial
Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma PHASE1 The purpose of this study is to determine if BMS-663513 administered in com...
Show More Location
Local Institution
Learn More & Join Trial
Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma EARLY_PHASE1 The purpose of this Pilot Study is to investigate the safety, side effects,...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas PHASE2 This platform trial will evaluate various immunotherapy combinations given ...
Show More Status
Active Not Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Learn More & Join Trial
A Study of BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies PHASE1 The purpose of this study is to assess the safety and tolerability of multi...
Show More Location
University Of Pennsylvania Medical Center
Learn More & Join Trial
Urelumab (CD137 mAb) With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients PHASE2 The goal of this clinical research study is to learn if urelumab given in c...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma PHASE1 The purpose of the study is to assess the safety, tolerability, pharmacokin...
Show More Location
Division Of Hematology & Oncology Ctr. For Health Sciences
Learn More & Join Trial
Phase II, 2nd Line Melanoma - RAND Monotherapy PHASE2 The main purpose of this study is to estimate the proportion of patients wi...
Show More Location
The Angeles Clinic & Research Institute
Learn More & Join Trial